Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOUNCE THERAPEUTICS, INC.

(JNCE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about JOUNCE THERAPEUTICS, INC.
09/15JOUNCE THERAPEUTICS : Departures of Directors or Certain Officers; Election of Directors; ..
PU
09/15Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
GL
09/15Jounce Therapeutics, Inc. Announces Board Changes
CI
09/14JOUNCE THERAPEUTICS : Raymond James Upgrades Jounce Therapeutics to Outperform From Market..
MT
09/02Jounce Therapeutics to Present at Upcoming Investor Conferences in September
GL
08/05Jounce Therapeutics Reports Second Quarter 2021 Financial Results
GL
08/05Jounce Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30..
CI
07/29Jounce Therapeutics to Announce Second Quarter 2021 Financial Results and Host a Confer..
GL
07/07JOUNCE THERAPEUTICS : to Participate in William Blair's Biotech Focus Conference
AQ
06/25JOUNCE THERAPEUTICS, INC.(NASDAQGS : JNCE) dropped from Russell 2000 Defensive Index
CI
06/25JOUNCE THERAPEUTICS, INC.(NASDAQGS : JNCE) dropped from Russell 2000 Value-Defensive Index
CI
06/23Jounce Therapeutics Provides Update on INNATE Study and Discovery Pipeline Expansion, a..
GL
06/16Jounce Therapeutics to Host Virtual R&D Day on June 23, 2021
GL
06/15UPDATE : Jounce Therapeutics to Get $25 Million From Gilead Sciences After FDA Clears Canc..
MT
06/15Jounce Therapeutics Shares Rise 13% on IND Clearance for Cancer Treatment
DJ
More most relevant news
All news about JOUNCE THERAPEUTICS, INC.
09/15JOUNCE THERAPEUTICS : Departures of Directors or Certain Officers; Election of Directors; ..
PU
09/15JOUNCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/15Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
GL
09/15Jounce Therapeutics, Inc. Announces Board Changes
CI
09/15NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
09/14JOUNCE THERAPEUTICS : Raymond James Upgrades Jounce Therapeutics to Outperform From Market..
MT
09/02Jounce Therapeutics to Present at Upcoming Investor Conferences in September
GL
08/05JOUNCE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/05Jounce Therapeutics Reports Second Quarter 2021 Financial Results
GL
08/05JOUNCE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial State..
AQ
More news
News in other languages on JOUNCE THERAPEUTICS, INC.
2018WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
More news
Analyst Recommendations on JOUNCE THERAPEUTICS, INC.
09/14JOUNCE THERAPEUTICS : Raymond James Upgrades Jounce Therapeutics to Outperform From Market..
MT
03/15JOUNCE THERAPEUTICS : Piper Sandler Starts Jounce Therapeutics at Overweight With $20 Pric..
MT
2020JOUNCE THERAPEUTICS : HC Wainwright Starts Jounce Therapeutics at Buy With $11 Price Targe..
MT
2020JOUNCE THERAPEUTICS : Roth Capital Adjusts Jounce Therapeutics PT to $15 From $28, Maintai..
MT
2020JOUNCE THERAPEUTICS : Raymond James Downgrades Jounce Therapeutics to Market Perform From ..
MT
More recommendations
Press releases
09/15JOUNCE THERAPEUTICS : Departures of Directors or Certain Officers; Election of Directors; ..
PU
09/15JOUNCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/15Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors
GL
09/02Jounce Therapeutics to Present at Upcoming Investor Conferences in September
GL
08/05JOUNCE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
More press releases
Upcoming event on JOUNCE THERAPEUTICS, INC.